Skip to main content

Published locations for OA drug development needs patient-focused approach to biomarkers and outcome measures

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. OA drug development needs patient-focused approach to biomarkers and outcome measures

User login

  • Reset your password
  • /content/oa-drug-development-needs-patient-focused-approach-biomarkers-and-outcome-measures
  • /familypracticenews/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused-approach
  • /internalmedicinenews/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused
  • /rheumatologynews/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused-approach
  • /rheumatology/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused-approach
  • /internalmedicine/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused-approach
  • /familymedicine/article/120115/osteoarthritis/oa-drug-development-needs-patient-focused-approach